About Sobi

We care about patients with rare diseases

Sobi is a leading biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of patients with rare diseases and their families.

  • Key therapeutic areas are Inflammation and Genetics & Metabolism.
  • Our late stage pipeline includes three phase III programs with substantial potential.
  • We have world-class capabilities in protein biochemistry and biologics manufacturing development - validated by leading industry partners.


Global reach

The Sobi head office is in Stockholm, Sweden. We are an organisation covering about 20 European countries, Middle East, Africa and the US.

Sobi UK covers: United Kingdom, Republic of Ireland and British Overseas Territories. .